Profiles for companies starting with 'j'
✉ Email this page to a colleague
Drugs and US Patents for j
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant Generics | TELMISARTAN | telmisartan | TABLET;ORAL | 204164-002 | Aug 22, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Janssen Pharms | INVOKANA | canagliflozin | TABLET;ORAL | 204042-002 | Mar 29, 2013 | RX | Yes | Yes | 7,943,788 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Jubilant Generics | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 090839-005 | Nov 4, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate | TABLET;ORAL | 216793-002 | Aug 11, 2023 | RX | Yes | Yes | 11,207,311 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |